Deucravacitinib Long-Term Efficacy in Week 16 Placebo Crossovers: 3-year Results from the POETYK PSO Program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s365, 2024. DOI: 10.25251/skin.8.supp.365. Disponível em: https://skin.dermsquared.com/skin/article/view/2672. Acesso em: 2 may. 2026.